In development
RCS-01 is an autologous cell therapy in development for aging and sun-damaged skin. It uses non-bulbar dermal sheath (NBDS) cells, a type of fibroblast, isolated from the patient’s own hair follicles.
Fibroblasts contribute to connective tissue by producing structural proteins, including collagen. NBDS cells, which are the focus of RepliCel’s patented technologies, produce type 1 and type 2 collagen.
For RCS-01, NBDS cells are isolated from a small tissue sample taken from the back of the patient’s scalp, expanded in culture, and injected beneath the skin.